Introduction
Osteoblasts produce and secrete several kinds of growth factors that are also found in the extracellular matrix of bone, such as fibroblast growth factor 2 (FGF2), transforming growth factor-β (TGF-β), and platelet-derived growth factor (PDGF). These growth factors may regulate the initiation and development of bone formation and fracture callus. A particularly close relationship between FGF2 and bone formation has been reported (1, 2) . Overexpression of the FGF2 gene in transgenic mice causes premature mineralization, flattening and shortening of long bones (3) . Moreover, disruption of the FGF2 gene leads to a decrease of both bone mass and bone formation (4) . Therefore, FGF2 could be crucial for the regulation of osteoblast proliferation and proper bone development.
Forskolin (FSK) is a labdane diterpene produced by the Indian Coleus plant. FSK is commonly used to raise cyclic AMP (cAMP) levels in studies of cell physiology. FSK resensitizes cell receptors by activating the enzyme adenylyl cyclase and increasing the intracellular levels of cAMP. Neurotransmitters and parathyroid hormone (PTH), which stimulate cAMP production and activation of protein kinase A (PKA) (5) , can promote (6) or inhibit (7) growth and proliferation in a cell-specific manner. FSK and 8-Br cAMP, which also elevate the intracellular level of cAMP, together with PTH, have been shown to increase the levels of both osteocalcin (OC) mRNA and protein (8) .
OC and bone sialoprotein (BSP) are non-collagenous proteins expressed specifically in mineralized connective tissues (9) . OC is expressed in bone matrix at the late stage of mineralization, whereas BSP is expressed in the early stage. The temporo-spatial deposition of BSP in the extracellular matrix of bone (10) and its ability to nucleate hydroxyapatite crystal formation (11) indicate a potential role of BSP in the initial mineralization of bone. Several studies have shown that FGF2 and FSK (cAMP) induce expression of the OC gene (12, 13) , and that Msx2, Dlx5 and Runx2 are important transcription factors for OC gene expression (13) (14) (15) (16) (17) . A low concentration of FSK induces differentiation of osteoprogenitor cells, possibly through a non-cAMP-dependent process, and intermittent elevation of intracellular cAMP has an inhibitory effect on bone formation (18) . Moreover, FSK inhibits DNA synthesis, blocks protein kinase C (PKC)-stimulated tyrosine phosphorylation of p44MAPK (ERK1) and p42MAPK (ERK2), and also inhibits PKC-stimulated MAPK and Raf-1 activities in MC3T3-E1 osteoblastlike cells (19) . Phorbol-12-myristate-13-acetate (PMA) activates the intermediate MKK step of the Raf-1/MKK/ MAPK cascade in the presence of FSK (20) . Inducible cAMP early repressor (ICER) expression in osteoblasts also requires activation of the cAMP-protein kinase A (PKA) signaling pathway (20) . We have previously reported that FGF2 and FSK (FGF/FSK) synergistically upregulate BSP gene expression through PKA, tyrosine kinase, and MAP-kinase-dependent pathways, which target the inverted CCAAT, CRE, FRE and Pit-1 elements in the rat BSP gene promoter (21) .
The goal of the present study was to use microarray and real-time PCR to investigate the candidate genes associated with mineralization after stimulation by FGF2, FSK and FGF/FSK.
Materials and Methods

Reagents
Alpha minimum essential medium (α-MEM), fetal calf serum (FCS), penicillin, streptomycin, and trypsin were obtained from Invitrogen (Carlsbad, CA, USA). A DyNAmo SYBRgreen qPCR Kit and Moloney murine leukemia virus reverse transcriptase RNase H were from Finnzymes (Espoo, Finland). FSK was from SigmaAldrich Japan (Tokyo, Japan). Recombinant human FGF2 was from Genzyme, Techne (Minneapolis, MN, USA). GeneChip (Human Genome U133A 2.0 Array and Rat Genome 230 2.0 Array) was purchased from Affymetrix (Santa Clara, CA, USA). All chemicals used were of analytical grade.
Cell culture
Human and rat osteoblast-like Saos2 and ROS17/2.8 cells were cultured at 37°C in 5% CO 2 air in α-MEM supplemented with 10% FCS. These cells were first grown to confluence in 60-mm tissue culture dishes in α-MEM medium containing 10% FCS, then cultured in α-MEM without serum for 12 h, and stimulated by FGF2 (10 ng/mL), FSK (1 μM) or FGF2/FSK for 6 h. Total RNA was isolated from triplicate cultures and analyzed for gene expression.
Microarray analysis
Three RNA samples were mixed together for gene expression profiling, which was performed separately for each pooled RNA sample using a GeneChip (Human Genome U133A 2.0 Array, spotted with 22,000 human genes, and Rat Genome 230 2.0 Array, spotted with 28,000 rat genes). Hybridization and scanning of the Gene Chip were done in accordance with the Affymetrix manual. Twenty micrograms of the fragmented biotinylated sample cRNA was hybridized to the GeneChip, and then washed and stained with streptavidin-phycoerythrin (Molecular Probes, Eugene, OR, USA) using the EukGE-WS1 protocol by an Affymetrix GeneArray Scanner. The expressions of human and rat genes were monitored, and the data were imported into GeneSpring GX software (Agilent Technologies, Inc, Santa Clara, CA, USA)
Real-time PCR Quantitative real-time PCR was performed using a SYBR Green qPCR Kit in a DNA Engine Opticon 2 continuous fluorescence detection system (BioRad, Hercules, CA, USA). After the RT reaction, cDNA was used as the template for real-time quantitative PCR for human WNT5A, human WNT5B, human HADC4, rat JUNB, rat MYC, rat AXIN2, rat WNT4, and rat c-FOS; human and rat GAPDH were utilized as internal controls. Details of the primers are listed in Table 1 . The amplification reactions were performed in a final volume of 20 μL containing 1× SYBR Green Master Mix, 0.25 μM primer mixture and 10 ng cDNA. To reduce variability between replicates, PCR premixes, which contained all of the reagents except for cDNA, were prepared and aliquoted into 0.2-mL thin-walled strip tubes (MJ Research Inc.). The thermal cycling conditions were 30 cycles of the following protocol: 15 s of denaturation at 95°C, 50 s of annealing at 64°C, followed by 12 s of extension at 77°C. Post-PCR melting curves confirmed the specificity of single-target amplification, and the expression of target genes relative to GAPDH was determined from triplicate samples.
Statistical analysis
Triplicate samples were analyzed for each experiment, and experiments were replicated to ensure consistency of the responses to stimulation. Significant differences between controls and treatments were determined using one-way analysis of variance (ANOVA).
Results
To study the regulation of human and rat genes by FGF2, FSK or FGF2/FSK, we performed DNA microarray analyses of total RNA extracted from Saos2 and ROS17/2.8 osteoblast-like cells. In human Saos2 cells, the expression levels of 418, 68 and 345 genes were upregulated more than two-fold by FGF2 (10 ng/mL), FSK (1 μM) and FGF/FSK in Saos2 cells (Table 2 A, B, C). FGF2 increased the expression of mRNAs for synaptotagmin XII (SYT12) (60.2-fold), osteopontin (SPP1(OPN), 16.7-fold), colony stimulating factor 2 (CSF2, 15.6-fold), early growth response 1 (EGR1, 6.6-fold), interleukin 8 (IL8 6.4-fold), interleukin 11 (IL11, 4.8-fold), Wnt5B (WNT5A, 4.0-fold), histone deacetylase 4 (HDAC4, 3.5-fold), and bone morphogenetic protein 2 (BMP2, 3.3-fold) (Table 2A) . FSK stimulated expression of the genes for sialophorin (LSN, 45.2-fold), synaptotagmin-like 3 (SYTL3, 6.1-fold), IL11 (4.0-fold), prostaglandin E synthase (PTGES, 2.9-fold), chemokine ligand 13 (CXCL13, 2.8-fold), IL6 (2.6-fold), and BMP2 (2.5-fold) (Table 2B ). FGF/FSK induced the expression of mRNAs for SYTL3 (33.9-fold), IL11 (13.6-fold), SPP1 (12.4-fold), CSF2 (10.3-fold), HDAC4 (7.5-fold), EGR1 (6.8-fold), IL8 (5.6-fold), BMP2 (4.4-fold), and WNT5A (4.1-fold) (Table 2C) .
In rat ROS17/2.8 cells, the expression levels of 591, 127 and 390 genes were upregulated more than two-fold by FGF2 (10 ng/mL), FSK (1 μM) and FGF/FSK (Table  3 A, B, C). FGF2 stimulated expression of the genes for dentin matrix protein 1 (DMP1, 129.8-fold), EGR1 (33.4-fold), c-FOS (7.2-fold), AXIN2 (4.6-fold), JUNB (4.1-fold), MYC (3.8-fold), and connective tissue growth factor (CTGF, 2.8-fold) (Table 3A) . FSK increased Table 1 The primers used for real-time PCR analysis in this study Gene Primer sequences expression of the genes for c-FOS (10.7-fold), EGR1 (5.6-fold), HDAC4 (3.6-fold), AXIN2 (2.8-fold), WNT4 (2.4-fold), CTGF (2.1-fold) and IL6 (2.1-fold) (Table  3B) . Furthermore, FGF/FSK upregulated expression of the genes for amphiregulin (AREG, 73.0-fold), EGR1 (22.6-fold), DMP1 (13.4-fold), PTGES (6.4-fold), CTGF (4.5-fold), cAMP response element modulator (CREM, 4.1-fold), JUNB (3.8-fold), MYC (3.8-fold), and AXIN2 (3.5-fold) (Table 3C) . To investigate candidate genes associated with miner- . While FSK induced expression of the genes for WNT5A (5.5-fold) and HDAC4 (2.4-fold), it suppressed expression of the mRNA for WNT5B (0.17-fold). FGF/ FSK induced expression of the genes for WNT5A (11.8-fold), WNT5B (6.2-fold) and HDAC4 (6.5-fold). Next, we performed real-time PCR to examine the mRNA levels of the candidate genes associated with mineralization after stimulation by FGF2, FSK and FGF/FSK in rat osteoblast-like ROS17/2.8 cells. FGF2 increased expression of the genes for c-FOS (2.1-fold), AXIN2 (5.1-fold), and MYC (2.4-fold). In contrast, FGF2 suppressed expression of the mRNAs for JUNB (0.4-fold) and WNT4 (0.43-fold). FSK increased expression of the genes for c-FOS (4.37-fold), AXIN2 (4.5-fold), JUNB (1.53-fold), MYC (1.6-fold) and WNT4 (2.8-fold). While FGF/FSK induced expression of the genes for c-FOS (1.2-fold), AXIN2 (10.1-fold), and MYC (3.9-fold), it reduced that of the genes for JUNB (0.43-fold) and WNT4 (0.45-fold). When we compared the mRNA levels of c-FOS, JUNB and WNT4 in rat osteoblast-like ROS17/2.8 cells after stimulation by FGF2, FSK and FGF/FSK, c-FOS mRNA levels were increased by FGF2 (2.1 ± 0.67-fold), FSK (4.37 ± 0.87-fold), and FGF/FSK (1.2 ± 0.55-fold). JUNB gene expression was induced by FGF2 (0.4 ± 0.06-fold), FSK (1.53 ± 0.22-fold), and FGF/FSK (0.43 ± 0.19-fold). Expression of WNT4 mRNA was induced by FGF2 (0.43 ± 0.08-fold), FSK (2.8 ± 0.1-fold), and FGF/FSK (0.45 ± 0.09-fold). Therefore, FSK increased the expression of these three genes to a maximal extent (Fig. 3) .
Discussion
In this study, we investigated candidate genes associated with mineralization induced by FGF2, FSK and FGF/FSK in two osteoblast-like cell lines (Tables 2  and 3 ). These genes were distinguished from various fields depending on cell type, such as regulators of gene expression (c-FOS, JUNB, MYC, WNT5 and HDAC4), extracellular matrix proteins (OC, OPN and DMP1), and inflammatory cytokines (IL6, IL8, IL1 and PTGES). Moreover, using real-time PCR, we focused on some inducible genes associated with mineralization induced by FGF2, FSK and FGF/FSK.
The levels of WNT5A and HDAC4 mRNA were increased by each of FGF2, FSK and FGF/FSK in human osteoblast-like Saos2 cells. While expression of the WNT5B gene was induced by FGF2, it was decreased by FSK. WNT5A and WNT5B belong to the WNT family, and it is well known that the Wnt signaling pathway also plays a pivotal role in the regulation of bone mass (22) . The Wnt signaling pathway is activated during postnatal bone regenerative events, such as ectopic endochondral bone formation and fracture repair. It has been reported that FGF signaling is able to control many aspects of osteoblast differentiation through induction of SOX2 and regulation of the Wnt/β-catenin pathway (23). Ambrosetti et al. showed that ERK1/2 and Akt exert distinct effects on FGF-induced osteoblast proliferation and differentiation (24) . The Wnt signaling pathway, which promotes osteoblast differentiation, also induces Akt phosphorylation. Cells expressing active Akt increase the levels of stabilized β-catenin and Wnt signaling (25) . Takada et al. reported that histonelysine methyltransferase activated by non-canonical Wnt signaling suppresses PPAR-gamma transactivation, induces Runx2 expression, and promotes osteoblastogenesis (26) . These results suggest a close relationship between FGF2, Wnt and osteoblastogenesis.
HDAC4 is one of the histone deacetylases (HDACs) (27) , and is known to regulate osteoblast differentiation. HDAC4 or HDAC5 is required for TGF-β-mediated inhibition of Runx2 function and is involved in osteoblast differentiation (28) . HDAC4 deacetylates Runx2, Experiments were performed in triplicate for each data point, and standard errors are shown as vertical lines. Significant differences compared to controls are shown at the following probability levels: *P < 0.01, **P < 0.05.
allowing the protein to undergo Smurf-mediated degradation. Inhibition of HDAC4 increases Runx2 acetylation and potentiates BMP-2-stimulated osteoblast differentiation, thus increasing bone formation (29) . PTH regulates HDAC4 in osteoblast-like cells through a PKA-dependent pathway, leading to removal of HDAC4 from the MMP13 gene promoter and enhancing gene transcription (30) . These findings suggest that HDAC4 could be related to the transcription factors induced by FGF and FSK in osteoblasts. The level of WNT4 mRNA was increased by FSK but not by FGF2. AXIN2 gene expression was induced by each of FGF2, FSK and FGF/FSK. Also, the level of c-MYC mRNA was increased by FGF2 and FGF/ FSK in ROS17/2.8 cells. AXIN2/conductin/Axil is a negative regulator of the canonical Wnt pathway that suppresses signal transduction by promoting degradation of β-catenin. AXIN2 has a role in calvarial morphogenesis and craniosynostosis (31) . Studies of the function of AXIN2 and β-catenin have demonstrated that canonical signaling modulates most aspects of osteoblast physiology including proliferation, differentiation, bone matrix formation/mineralization and apoptosis, as well as coupling to osteoclastogenesis and bone resorption.
Activator protein 1 (AP1) transcription factor is formed by the c-FOS and c-JUN heterodimer. c-FOS is a key regulator of osteoblast differentiation, whereas, c-JUN, JUNB and FRA1 are essential for embryonic and/or postnatal development (32) . We have previously reported that FGF2 stimulates BSP gene transcription by targeting the FGF2 response element (FRE) and AP1/ glucocorticoid response element (GRE) in the rat BSP gene promoter (33) . In the present study, c-FOS expression was induced by FGF2 and FSK. DNA microarray analyses demonstrated that the level of JUNB mRNA was increased by FGF2 and FGF/FSK in ROS 17/2.8 cells (Table 3) , whereas real-time PCR indicated that FGF2 and FGF/FSK were unable to induce JUNB gene expression, and that FSK induced JUNB mRNA to a maximal extent (Fig. 3) . Further study to clarify the reason for this discrepancy is required. Osteoblast-specific extracellular matrix proteins such as OC and BSP are known to be markedly reduced in JUNB-deficient mice (34) .
Glucocorticoid increases the expression of mRNAs for alkaline phosphatase (ALP), c-MYC, c-FOS and c-JUN in human osteoblast-like cells (35) . c-MYC induces differentiation and apoptosis of human ES cells (36) , whereas LIF and STAT3 regulate ES cell self-renewal and pluripotency by a MYC-dependent mechanism (37) . Takahashi et al. demonstrated that the four transcription factors OCT3/4, SOX2, KLF4 and c-MYC generated induced pluripotent stem cells (iPS cells) from adult human dermal fibroblasts (38) . Thus, c-MYC has a close connection with cell differentiation and proliferation, and may have a role in the differentiation and proliferation of osteoblasts upon stimulation with FGF2.
In conclusion, our present findings suggest that FGF2, FSK and FGF/FSK induce many mineralizationassociated genes. Therefore, the induced genes may interact with each other to regulate bone mineralization and formation.
